Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo Aleman

Showing results (61-70 of 143) with videos related to

Pageof 15
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|October 31, 2023
The cascade of care for patients with chronic hepatitis delta in Southern Stockholm, Sweden for the past 30 yearsHabiba Kamal, Karin Lindahl, Michael Ingre, et al.
Scandinavian Journal of Gastroenterology|June 17, 2011
Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general populationSoo Aleman, Sanam Endalib, Per Stål, et al.
Clinics and Research in Hepatology and Gastroenterology|March 19, 2021
Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapyJeffrey V Lazarus, Camila A Picchio, Danielle Guy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 2, 2012
TCR-redirected human T cells inhibit hepatitis C virus replication: hepatotoxic potential is linked to antigen specificity and functional avidityAnna Pasetto, Lars Frelin, Soo Aleman, et al.
Journal of Clinical Immunology|May 10, 2022
Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron VariantHannes Lindahl, Jonas Klingström, Rui Da Silva Rodrigues, et al.
Journal of Viral Hepatitis|January 6, 2026
Trends of Advanced Chronic Liver Disease Among 17,711 Persons in Mongolia During Years 2015-2023Habiba Kamal, Ganbolor Jargalsaikhan, Sanjaasuren Enkhtaivan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2013
A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosisSoo Aleman, Nogol Rahbin, Ola Weiland, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 26, 2026
From Diagnosis to Durability: A Review of the European Bulevirtide Experience and Practical Learnings for CHD ManagementMonica Radu, Margarita Papatheodoridi, Habiba Kamal Khodir, et al.
Journal of Clinical Immunology|March 15, 2022
Elevated CD21<sup>low</sup> B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable ImmunodeficiencyPeter Bergman, David Wullimann, Yu Gao, et al.
Scientific Reports|August 1, 2024
Exploring the interplay between antiretroviral therapy and the gut-oral microbiome axis in people living with HIVAswathy Narayanan, Oscar Kieri, Jan Vesterbacka, et al.
Pageof 15

Showing results (61-70 of 143) with videos related to

Sort By:
Pageof 15
Liver International : Official Journal of the International Association for the Study of the Liver|October 31, 2023
The cascade of care for patients with chronic hepatitis delta in Southern Stockholm, Sweden for the past 30 yearsHabiba Kamal, Karin Lindahl, Michael Ingre, et al.
Scandinavian Journal of Gastroenterology|June 17, 2011
Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general populationSoo Aleman, Sanam Endalib, Per Stål, et al.
Clinics and Research in Hepatology and Gastroenterology|March 19, 2021
Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapyJeffrey V Lazarus, Camila A Picchio, Danielle Guy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 2, 2012
TCR-redirected human T cells inhibit hepatitis C virus replication: hepatotoxic potential is linked to antigen specificity and functional avidityAnna Pasetto, Lars Frelin, Soo Aleman, et al.
Journal of Clinical Immunology|May 10, 2022
Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron VariantHannes Lindahl, Jonas Klingström, Rui Da Silva Rodrigues, et al.
Journal of Viral Hepatitis|January 6, 2026
Trends of Advanced Chronic Liver Disease Among 17,711 Persons in Mongolia During Years 2015-2023Habiba Kamal, Ganbolor Jargalsaikhan, Sanjaasuren Enkhtaivan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2013
A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosisSoo Aleman, Nogol Rahbin, Ola Weiland, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 26, 2026
From Diagnosis to Durability: A Review of the European Bulevirtide Experience and Practical Learnings for CHD ManagementMonica Radu, Margarita Papatheodoridi, Habiba Kamal Khodir, et al.
Journal of Clinical Immunology|March 15, 2022
Elevated CD21<sup>low</sup> B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable ImmunodeficiencyPeter Bergman, David Wullimann, Yu Gao, et al.
Scientific Reports|August 1, 2024
Exploring the interplay between antiretroviral therapy and the gut-oral microbiome axis in people living with HIVAswathy Narayanan, Oscar Kieri, Jan Vesterbacka, et al.
Pageof 15